Market research
600351.SHG Yabao Pharmaceutical Group Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 14.11
- Analyst target
- 10.8
- Dividend yield
- 8.2%
- Beta
- 0.04
Community
Investor discussion
1 comment
Sign in to join the 600351.SHG discussion.
5 years, 5 months ago
Yabao Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 8.3% above its 200 day moving average.
From a valuation standpoint, the stock is 84.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Yabao Pharmaceutical Group Co., Ltd's total revenue sank by 7.1% to $700M since the same quarter in the previous year.
Its net income has dropped by 53.7% to $31M since the same quarter in the previous year.
Finally, its free cash flow fell by 57.4% to $26M since the same quarter in the previous year.
Based on the above factors, Yabao Pharmaceutical Group Co., Ltd gets an overall score of 2/5.